Wird geladen...

Update to Drugs, Devices, and the FDA: How Recent Legislative Changes Have Impacted Approval of New Therapies

Two major legislative actions since 2015, the 21st Century Cures Act of 2016 and the U.S. Food and Drug Administration (FDA) Reauthorization Act of 2017, contain significant provisions that potentially streamline drug development times, and by extension, may reduce costs. Evidence suggests, however,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JACC Basic Transl Sci
1. Verfasser: Van Norman, Gail A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2020
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7444905/
https://ncbi.nlm.nih.gov/pubmed/32864509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacbts.2020.06.010
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!